Is NESTROFT better than the hematological indices for screening of beta-thalassemia trait: an answer in rural scenario

Journal Title: Indian Journal of Pathology and Oncology - Year 2017, Vol 4, Issue 1

Abstract

Introduction: Clinical and pathological distinction between beta thalassemia trait (š¯›½-TT) and iron deficiency anemia (IDA) is of paramount importance. On day to day basis, these two are differentiated by many hematological indices which are derived by mathematical calculations. In this scenario, naked eye single tube red cell osmotic fragility test (NESTROFT) has been slightly relegated. The aim of the present study was to compare by statistical means the standings of these indicators with NESTROFT and also measure efficiency of both by Youdenā€™s index. Material & Methods: The study was conducted on 225 patients diagnosed with mild microcytic hypochromic anemia on complete blood count and PBF. 12 discrimination indices were calculated with simultaneous NESTROFT and HbA2 levels estimation. The results were compiled and analyzed by statistical means. Results: The Shine & Lal and Ricerca et al indices exhibited the highest sensitivity of 100% each while The England & Fraser index demonstrated the highest specificity of 90.2%. The highest PPV was found for Mentzer index(77.3%). The highest NPV was found for Ricerca et al & Shine & Lal indices of 100% each. The highest Youdenā€™s index was shown by Mentzer index(81.3%). NESTROFT showed a sensitivity, specificity, PPV and NPV of 98.6%, 83.7%, 74.0%, 99.2% respectively. The Youdenā€™s index for NESTROFT was 82.3%. Conclusion: NESTROFT proved to be a better test than all other hematological indices for detection of š¯›½-TT. It scores due to its good statistical end results including good efficiency indicator. Additionally, it is observed that it is a test with good cost benefit ratio, easy performability and does not require tedious and hi-tech equipment. Hence NESTROFT should be the primary screening tool for beta thalassemia trait.

Authors and Affiliations

Sanjay Piplani, Manjot Kaur, Manas Madan, Monika Lalit

Keywords

Related Articles

Role of Fine needle aspiration cytology in Head and neck lesions

Introduction The common head and neck lesions encountered in routine daily practice are from lymph nodes, salivary glands, soft tissue tumors, and thyroid. The beginning inexpensive diagnostic procedure that the clinicia...

Study of transfusion transmitted infections among blood donors in a Tertiary care Hospital in Puducherry

Introduction: Transfusion of blood and its components is a life-saving procedure as even a unit of blood can save a patient in need. Though it is said to be a safe procedure as the blood is tested and processed before it...

A cross sectional study of the reasons for deferral of voluntary blood donors at a district blood bank attached to a medical college hospital in southern Karnataka

Introduction The study objectives were to determine the demographic profile of voluntary donors who were deferred from donating blood and the different reasons for deferral of those donors who intended to donate blood to...

Role of thoracoscopic pleural biopsy in evaluation of pleural effusion

Context Evaluation of a patient with pleural effusion involves clinical radiological and cytological evaluation of pleural fluid and histological evaluation of pleural biopsy It is not always possible to identify the exa...

Clinical and histopathological study of oral cancers in a tertiary care hospital, Tumakuru

India is a country where chewing pan, beetle-areca with lime is common among all age group. External and local irritation of buccal mucosa is associated with high risk of cancer. It may begin as a local lesion or by meta...

Download PDF file
  • EP ID EP311384
  • DOI 10.18231/2394-6792.2017.0013
  • Views 100
  • Downloads 0

How To Cite

Sanjay Piplani, Manjot Kaur, Manas Madan, Monika Lalit (2017). Is NESTROFT better than the hematological indices for screening of beta-thalassemia trait: an answer in rural scenario. Indian Journal of Pathology and Oncology, 4(1), 63-70. https://europub.co.uk/articles/-A-311384